In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on ProQR (PRQR – Research Report), with a price target of ...

ProQR (PRQR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jonathan Wolleben from JMP ...

Recent research published in the journal “Science Bulletin” detailed the creation of a tool called ChCas12b that can ...

To begin the process of gene editing using CRISPR technology, employ a guide RNA to pinpoint the desired sequence, followed ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.08, a high estimate of $13.00, ...

In molecular biology, RNA modifications were traditionally associated with static structural components like rRNAs and tRNAs. However, advancements such as antibody immunoprecipitation and ...

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through ...

Elevate your manuscript with top editors.

I am glad that these negative results are finally shared, as it helps prevent duplication of work and unnecessary suffering in laboratory animals.” ...